Table 1 Patients’ characteristics and clinical data
Parameter | Diabetic | Non-diabetic | ||||
|---|---|---|---|---|---|---|
Lean | Overweight | Obese | Lean | Overweight | Obese | |
Total number (N) | 11 | 18 | 24 | 24 | 23 | 25 |
Male (N) | 7 | 9 | 14 | 10 | 7 | 11 |
Female (N) | 4 | 9 | 10 | 14 | 16 | 14 |
Age (Yrs.) | 28–58 | 36–61 | 23–75 | 21–61 | 23–60 | 28–66 |
Body mass index (kg/m2) | 23.9 ± 1.6 | 27.7 ± 1.5 | 33.9 ± 2.5 | 22.4 ± 1.9 | 27.1 ± 1.5 | 34.8 ± 3.6 |
Body fat percentage | 28.9 ± 4.9 | 33.5 ± 5.9 | 36.9 ± 5.5 | 31.3 ± 5.1 | 33.8 ± 4.6 | 39.1 ± 5.0 |
Fasting plasma glucose (mmol/L) | 7.9 ± 2.6 | 7.5 ± 2.8 | 8.7 ± 2.6 | 5.1 ± 0.8 | 5.2 ± 0.4 | 5.6 ± 0.9 |
Glycated hemoglobin (HbA1c) (%) | 7.4 ± 1.8 | 6.9 ± 1.3 | 8.7 ± 1.9 | 5.5 ± 0.5 | 5.6 ± 0.4 | 6.0 ± 1.5 |
Total cholesterol (mmol/L) | 5.1 ± 1.3 | 5.1 ± 2.0 | 5.2 ± 1.2 | 4.9 ± 1.1 | 5.2 ± 0.9 | 3.6 ± 0.9 |
High-density lipoprotein (mmol/L) | 1.4 ± 1.0 | 1.2 ± 0.5 | 1.2 ± 0.3 | 1.4 ± 0.4 | 1.4 ± 0.5 | 1.2 ± 0.3 |
Low-density lipoprotein (mmol/L) | 3.2 ± 0.7 | 3.3 ± 1.7 | 3.2 ± 1.0 | 3.2 ± 0.8 | 3.2 ± 0.8 | 3.5 ± 0.9 |
Triglycerides (mmol/L) | 1.3 ± 0.8 | 1.6 ± 1.4 | 2.0 ± 1.6 | 0.8 ± 0.3 | 1.1 ± 0.6 | 1.3 ± 0.6 |
Hypertension (N) | 1 | 12 | 12 | 0 | 3 | 7 |
Hyperlipidemia (N) | 1 | 1 | 3 | 3 | 0 | 2 |
Therapy | Lipitor Insulin Aldomet | Metformin Lipitor Novorapid Concor | Metformin Diamicron NovoRapid Lipitor Concor | Lipitor | Lipitor Concor | Lipitor Aldomet Eltoxin |